These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9973365)

  • 41. Mycobacterium tuberculosis Rv1302 and Mycobacterium smegmatis MSMEG_4947 have WecA function and MSMEG_4947 is required for the growth of M. smegmatis.
    Jin Y; Xin Y; Zhang W; Ma Y
    FEMS Microbiol Lett; 2010 Sep; 310(1):54-61. PubMed ID: 20637039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular Dynamics Assisted Mechanistic Insight of Val430-Ala Mutation of Rv1592c Protein in Isoniazid Resistant
    Kumar A; Anand PK; Chandel S; Shrivatava A; Kaur J
    Curr Comput Aided Drug Des; 2021; 17(1):95-106. PubMed ID: 31939732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The two chorismate mutases from both Mycobacterium tuberculosis and Mycobacterium smegmatis: biochemical analysis and limited regulation of promoter activity by aromatic amino acids.
    Schneider CZ; Parish T; Basso LA; Santos DS
    J Bacteriol; 2008 Jan; 190(1):122-34. PubMed ID: 17965159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The characterization of conserved binding motifs and potential target genes for M. tuberculosis MtrAB reveals a link between the two-component system and the drug resistance of M. smegmatis.
    Li Y; Zeng J; Zhang H; He ZG
    BMC Microbiol; 2010 Sep; 10():242. PubMed ID: 20843371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The pMy vector series: A versatile cloning platform for the recombinant production of mycobacterial proteins in Mycobacterium smegmatis.
    Beckham KSH; Staack S; Wilmanns M; Parret AHA
    Protein Sci; 2020 Dec; 29(12):2528-2537. PubMed ID: 33006405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a Mycobacterium smegmatis transposon mutant array for characterising the mechanism of action of tuberculosis drugs: Findings with isoniazid and its structural analogues.
    Campen RL; Ackerley DF; Cook GM; O'Toole RF
    Tuberculosis (Edinb); 2015 Jul; 95(4):432-9. PubMed ID: 25936537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of novel loci associated with mycobacterial isoniazid resistance.
    Viswanathan G; Yadav S; Raghunand TR
    Tuberculosis (Edinb); 2016 Jan; 96():21-6. PubMed ID: 26786650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mycobacterium tuberculosis Arylamine N-Acetyltransferase Acetylates and Thus Inactivates para-Aminosalicylic Acid.
    Wang X; Yang S; Gu J; Deng J
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7505-7508. PubMed ID: 27671064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.
    Sim E; Abuhammad A; Ryan A
    Br J Pharmacol; 2014 Jun; 171(11):2705-25. PubMed ID: 24467436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cloning and expression of the trehalose-phosphate phosphatase of Mycobacterium tuberculosis: comparison to the enzyme from Mycobacterium smegmatis.
    Edavana VK; Pastuszak I; Carroll JD; Thampi P; Abraham EC; Elbein AD
    Arch Biochem Biophys; 2004 Jun; 426(2):250-7. PubMed ID: 15158675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mycobacterium tuberculosis dihydrofolate reductase is not a target relevant to the antitubercular activity of isoniazid.
    Wang F; Jain P; Gulten G; Liu Z; Feng Y; Ganesula K; Motiwala AS; Ioerger TR; Alland D; Vilchèze C; Jacobs WR; Sacchettini JC
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3776-82. PubMed ID: 20566771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional analyses of mycobacterial lipoprotein diacylglyceryl transferase and comparative secretome analysis of a mycobacterial lgt mutant.
    Tschumi A; Grau T; Albrecht D; Rezwan M; Antelmann H; Sander P
    J Bacteriol; 2012 Aug; 194(15):3938-49. PubMed ID: 22609911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sequence and structural characterization of tbnat gene in isoniazid-resistant Mycobacterium tuberculosis: identification of new mutations.
    Coelho MB; Costa ER; Vasconcellos SE; Linck N; Ramos RM; Amorim HL; Suffys PN; Santos AR; Silva PE; Ramos DF; Silva MS; Rossetti ML
    Mutat Res; 2011 Jul; 712(1-2):33-9. PubMed ID: 21514309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural and functional characterization of an arylamine N-acetyltransferase from the pathogen Mycobacterium abscessus: differences from other mycobacterial isoforms and implications for selective inhibition.
    Cocaign A; Kubiak X; Xu X; Garnier G; Li de la Sierra-Gallay I; Chi-Bui L; Dairou J; Busi F; Abuhammad A; Haouz A; Dupret JM; Herrmann JL; Rodrigues-Lima F
    Acta Crystallogr D Biol Crystallogr; 2014 Nov; 70(Pt 11):3066-79. PubMed ID: 25372695
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Swaminath S; Paul A; Pradhan A; Sebastian J; Nair RR; Ajitkumar P
    Microbiology (Reading); 2020 Feb; 166(2):180-198. PubMed ID: 31746727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis.
    Chaturvedi V; Dwivedi N; Tripathi RP; Sinha S
    J Gen Appl Microbiol; 2007 Dec; 53(6):333-7. PubMed ID: 18187888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase.
    Zhang W; Jones VC; Scherman MS; Mahapatra S; Crick D; Bhamidi S; Xin Y; McNeil MR; Ma Y
    Int J Biochem Cell Biol; 2008; 40(11):2560-71. PubMed ID: 18573680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistance.
    Pluvinage B; Dairou J; Possot OM; Martins M; Fouet A; Dupret JM; Rodrigues-Lima F
    Biochemistry; 2007 Jun; 46(23):7069-78. PubMed ID: 17511472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional complementation of the essential gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but not Escherichia coli fabG.
    Parish T; Roberts G; Laval F; Schaeffer M; Daffé M; Duncan K
    J Bacteriol; 2007 May; 189(10):3721-8. PubMed ID: 17337570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression and purification of immunologically reactive DPPD, a recombinant Mycobacterium tuberculosis skin test antigen, using Mycobacterium smegmatis and Escherichia coli host cells.
    Liu C; Flamoe E; Chen HJ; Carter D; Reed SG; Campos-Neto A
    Can J Microbiol; 2004 Feb; 50(2):97-105. PubMed ID: 15052311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.